INTERAÇÕES MEDICAMENTOSAS FRENTE AO USO DE ANTICONCEPCIONAIS ORAIS: UMA REVISÃO INTEGRATIVA DA LITERATURA
Palavras-chave:
Interações Medicamentosas, Anticoncepcionais Orais, AntirretroviraisResumo
O uso de métodos contraceptivos visando a não ocorrência de uma gravidez indesejada, é uma realidade na vida de boa parte das mulheres com vida sexual ativa no Brasil. Com tal finalidade, é possível citar diversos métodos empregados por homens e mulheres, a exemplo dos preservativos, o Dispositivo Intrauterino, bem como os anticoncepcionais orais, amplamente utilizados. Um quantitativo significativo de estudos na literatura aponta que o emprego conjunto de anticoncepcionais orais e antiepiléticos ou antibióticos ou antirretrovirais, poderia levar à ocorrência de interações medicamentosas. Sendo assim, tais interações promoveriam uma redução da eficácia do anticoncepcional, levando à gestação indesejada devido à falha contraceptiva, bem como à possível ocorrência de cenários adversos por interferência. Desta forma, o presente estudo visou realizar uma revisão integrativa da literatura a respeito das principais e possíveis interações medicamentosas envolvendo os anticoncepcionais orais e fármacos de outras classes, sendo estes: antibióticos; antirretrovirais; ademais, antiepiléticos.
Referências
AGUILAR, Sofia; ALVES, Maria José; SERRANO, Fátima. Pregnancy and epilepsy / Gravidez e epilepsia. Acta Obstétrica e Ginecológica Portuguesa, v. 10, n. 2, p. 120–129, 2016.
ANDERSON, Seri et al. Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs. Epilepsy & Behavior, v. 125, p. 108368, 2021.
ANKROM, Wendy et al. A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females. Journal of the International AIDS Society, v. 24, n. 12, p. e25858, 2021.
ARONSON, Jeffrey K.; FERNER, Robin E. Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives. BMJ Evidence-Based Medicine, v. 26, n. 3, p. 112-113, 2021.
BARCELLOS, Teresa et al. Effects of ritonavir-boosted protease inhibitors on combined oral contraceptive pharmacokinetics and pharmacodynamics in HIV-positive women. Contraception, v. 100, n. 4, p. 283-287, 2019.
BERRY-BIBEE, Erin N. et al. Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review. Contraception, v. 94, n. 6, p. 650-667, 2016.
BRANDT, Gabriela Pinheiro; OLIVEIRA, Ana Paula Rodrigues de; BURCI, Lígia Moura. Anticoncepcionais hormonais na atualidade: um novo paradigma para o planejamento familiar. Revista Gestão & Saúde, v. 18, n. 1, p. 54-62, 2018.
CHRISTENSEN, Jakob et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double‐blind, placebo‐controlled trial. Epilepsia, v. 48, n. 3, p. 484-489, 2007.
GOSSET, Anna et al. Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians. Epilepsy & Behavior, v. 129, p. 108627, 2022.
HOFFMANN, Kathryn et al. Oral contraceptives and antibiotics. A cross-sectional study about patients’ knowledge in general practice. Reproductive health, v. 12, p. 1-10, 2015.
LANDOLT, Nadia K. et al. Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women. JAIDS Journal of Acquired Immune Deficiency Syndromes, v. 66, n. 2, p. e50-e52, 2014.
LU, D. Y.; LU, T. R. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback. Adv Pharmacoepidem Drug Safety 1: e115. doi: 10.4172/2167-1052.1000.
LU, D. Y.; WU, H. Y.; LU, T. R. HIV/AIDS treatment, therapeutic strategy breakthroughs. Hos Pal Med Int Jnl, v. 4, n. 2, p. 34-39, 2020.
MACHADO, Fernanda Gomes et al. Anticoncepcionais orais combinados e aspectos clínicos. Research, Society and Development, v. 11, n. 14, p. e96111436097-e96111436097, 2022.
MAJEED, Sophia R. et al. Confirmation of the drug–drug interaction potential between cobicistat-boosted antiretroviral regimens and hormonal contraceptives. Antiviral Therapy, v. 24, n. 8, p. 557-566, 2019.
MARECOS, Clara; CUNHA, Manuel. Valproato e gravidez: riscos e consequências a propósito de três casos clínicos. Sinapse, v. 16, n. 2, p. 16–19, 2016.
MASTERS, Kelly P.; CARR, Beth M. Survey of pharmacists and physicians on drug interactions between combined oral contraceptives and broad-spectrum antibiotics. Pharmacy Practice (Granada), v. 7, n. 3, p. 139-144, 2009.
MEDEIROS, Emerson Augusto de; VARELA, Sarah Bezerra Luna; NUNES, João Batista Carvalho. Abordagem Qualitativa: estudo na pós-graduação em educação da Universidade Estadual do Ceará (2004–2014). Holos, v. 2, p. 174-189, 2017.
MOSELEY, Brian D. et al. A review of the drug− drug interactions of the antiepileptic drug brivaracetam. Epilepsy research, v. 163, p. 106327, 2020.
NANDA, Kavita et al. Drug interactions between hormonal contraceptives and antiretrovirals. Aids, v. 31, n. 7, p. 917-952, 2017.
NANDA, Kavita et al. Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness. Aids, v. 27, p. S17-S25, 2013.
PAREKH, Krishna; KRAVETS, Hannah Debra; SPIEGEL, Rebecca. Special considerations in the management of women with epilepsy in reproductive years. Journal of Personalized Medicine, v. 12, n. 1, p. 88, 2022.
PATEL, Rena C. et al. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. The lancet HIV, v. 2, n. 11, p. e474-e482, 2015.
POTTEGÅRD, Anton et al. Use of dicloxacillin and risk of pregnancy among users of oral contraceptives. Basic & Clinical Pharmacology & Toxicology, v. 123, n. 3, p. 288-293, 2018.
RAUCHENZAUNER, Markus et al. Bidirectional interaction between oral contraception and lamotrigine in women with epilepsy–role of progestins. Seizure, v. 74, p. 89-92, 2020.
REIMERS, Arne; BRODTKORB, Eylert; SABERS, Anne. Interactions between hormonal contraception and antiepileptic drugs: clinical and mechanistic considerations. Seizure, v. 28, p. 66–70, 2015. DOI: 10.1016/j.seizure.2015.03.006
SCARSI, Kimberly K. et al. Drug–drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV. Drug safety, v. 39, n. 11, p. 1053-1072, 2016.
SCHORETSANITIS, Georgios et al. Drug-drug interactions between psychotropic medications and oral contraceptives. Expert opinion on drug metabolism & toxicology, v. 18, n. 6, p. 395-411, 2022.
SEKAR, Vanitha J. et al. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women. Antiviral therapy, v. 13, n. 4, p. 563-569, 2008.
SIMMONS, Katharine B. et al. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. American journal of obstetrics and gynecology, v. 218, n. 1, p. 88-97. e14, 2018.
SOUZA, Marcela Tavares de; SILVA, Michelly Dias da; CARVALHO, Rachel de. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), v. 8, p. 102-106, 2010.
SRINIVASAN, Meenakshi et al. Quantifying the economic burden of unintended pregnancies due to drug–drug interactions with hormonal contraceptives from the United States payer perspective. Gates Open Research, v. 5, 2021.
TOH, Sengwee et al. Antibiotics and oral contraceptive failure—a case-crossover study. Contraception, v. 83, n. 5, p. 418-425, 2011.
WORLD HEALTH ORGANIZATION (WHO). 2023. "HIV" https://www.who.int/data/gho/data/themes/hiv-aids#:~:text=Global%20situation%20and%20trends%3A,at%20the%20end%20of%202021.
